0001209191-21-035536.txt : 20210524
0001209191-21-035536.hdr.sgml : 20210524
20210524194835
ACCESSION NUMBER: 0001209191-21-035536
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210506
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREGORY JULIA P
CENTRAL INDEX KEY: 0001226675
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39398
FILM NUMBER: 21956937
MAIL ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nurix Therapeutics, Inc.
CENTRAL INDEX KEY: 0001549595
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270838048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1130
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 205
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: (415) 660-5320
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 205
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: Nurix, Inc.
DATE OF NAME CHANGE: 20120509
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-06
0
0001549595
Nurix Therapeutics, Inc.
NRIX
0001226675
GREGORY JULIA P
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO
CA
94158
1
0
0
0
Director Stock Option (right to buy)
27.38
2021-05-06
4
A
0
17500
0.00
A
2031-05-05
Common Stock
17500
17500
D
The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 6, 2022, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
/s/ Christine Ring, as Attorney-in-Fact for Julia P. Gregory
2021-05-24